Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Ares closes $5.3bn for infrastructure secondaries strategy, tripling prior fund size
Ares closes $5.3bn for infrastructure secondaries strategy, tripling prior fund size Ares Management has closed $5.3bn for its Infrastructure Secondaries strategy, more than doubling its original $2bn target and marking one of the largest raises ever in the sector. ...
Paramount Skydance in talks with Apollo for potential $60bn Warner Bros. Discovery bid
Paramount Skydance in talks with Apollo for potential $60bn Warner Bros. Discovery bid Paramount Skydance chief executive David Ellison is in discussions with Apollo Global Management and other private equity investors to join a potential $60bn bid for Warner Bros....
Carlyle edges ahead in €6bn pursuit of BASF’s coatings division
Carlyle edges ahead in €6bn pursuit of BASF’s coatings division Carlyle Group has emerged as the leading bidder for BASF’s coatings business, in a deal that could value the division at around €6bn ($7bn), according to Bloomberg. The US buyout firm is negotiating final...